Boston Scientific Corporation has announced the US and European launch of a new platinum device for obstructing or reducing blood flow in the peripheral vasculature during embolisation procedures.

The Interlock – 35 Fibered IDC Occlusion System received clearance from the US Food and Drug Administration and CE Mark approval earlier this year.

It consists of a detachable platinum coil featuring an interlocking connection between the coil and delivery wire, which is designed to offer improved control of where it can be placed.

Boston explained that the platinum coil is constructed with a dense network of synthetic fibres, which offer doctors an "excellent" facility to block blood flow during operations.

Sally Mitchell, professor of radiology, surgery and paediatrics at The Johns Hopkins University School of Medicine in Baltimore, said the device could potentially reduce procedure times.

"The Interlock – 35 Coils offer a significant expansion of our best-in-class peripheral vascular coiling technology," added Joe Fitzgerald, president of Boston Scientific's Endovascular Unit.

He continued: "The dense network of fibres provides rapid thrombosis, and the availability of larger and longer coils aid in effective vessel occlusion."

Source:

  Boston Scientific Announces U.S. and European Launch of Interlock™ - 35 Fibered IDC™ Occlusion System (30/06/11) 

© Adfero Ltd